Status:
COMPLETED
Guanfacine Immediate-release Electrocardiogram Results (QTc) Study
Lead Sponsor:
Shire
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
To assess the effect of immediate-release guanfacine hydrochloride, administered at therapeutic and supratherapeutic doses, on QT/QTc in healthy normal males and females
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy Normal Subjects
Exclusion
Key Trial Info
Start Date :
April 18 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 7 2008
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00672984
Start Date
April 18 2008
End Date
August 7 2008
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles River Clinical Services Northwest, Inc.
Tacoma, Washington, United States